FDA Proposes Committee For Risk Communication

Law360, New York (June 5, 2007, 12:00 AM EDT) -- In an attempt to better communicate the risks and benefits of drugs to the public, the U.S. Food and Drug Administration said Monday that it is forming a new advisory committee.

The move to create the Risk Communication Advisory Committee comes the same week as a scheduled meeting in the U.S. House of Representatives to study the agency's assessment of safety of the diabetes drug Avandia.

The proposed committee will advise the FDA on the development of strategic plans to communicate product risks and benefits, and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.